Fluoroestradiol F-18

CHEMBL4594261 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
289.4 g/mol
LogP
3.5
Phase
4

This fluorine-18 labeled estradiol analog is used as a PET radiotracer to image estrogen receptor expression in breast cancer lesions.

Berat Molekul

289,4000 g/mol

LogP

3,50

TPSA

40,50 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H]([18F])[C@@H]2O

InChI

InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1/i19-1

Molecular Formula

C18H23FO2

HBD / HBA

2 / 3

Ikatan yang Dapat Dirotasi

0

Atom Berat

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This fluorine-18 labeled estradiol analog is used as a PET radiotracer to image estrogen receptor expression in breast cancer lesions.

Yes, Fluoroestradiol F-18 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594261. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10869981. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.